FDA Approved: ZEMBRACE SYMTOUCH — Original Application (Upsher-Smith laboratories, LLC)

View source ↗

Summary

FDA approved Zembrace SymTouch (sumatriptan succinate) from Upsher-Smith Laboratories as an original application for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ZEMBRACE SYMTOUCH (Sumatriptan succinate)

Snippet

ORIG AP for ZEMBRACE SYMTOUCH (SUMATRIPTAN SUCCINATE)